Latest News

Research suggests Nelfinavir and Cepharanthine as potential anti-SARS-CoV-2 agents




A new study published in the journal bioRxiv in April 2020 reports the identification of a promising multidrug treatment against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsible for causing COVID-19 disease. The team predicts that this combination will prevent the virus from reproducing, hence both halting the transmission and progress of the disease.

Source link

Related posts

Trump administration slashes funding to insurance navigator groups months ahead of open enrollment for ACA

Newsemia

Revision biceps tenodesis yielded high patient satisfaction rate

Newsemia

Startups wanted: Health 2.0 hosts VentureConnect events at JP Morgan, HIMSS19

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World